Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Quoin Pharmaceuticals secures up to $50 million in private placement financing, including $30.8 million upfront. The funding involves several healthcare-focused investors and provides further capital for company growth.

PUBLIC · QNRXAug 28, 2026about 3 hours ago

Amount Raised

$30.8 Million

Round Type

Post-IPO Equity

IsraelHealthcare

Investors

Stonepine Capital ManagementStem Point Capital LpNantahala CapitalAigh Capital ManagementSphera HealthcareSirenia Capital Management Lp

Description

Quoin Pharmaceuticals Ltd. has announced a securities purchase agreement to raise up to approximately $50 million. Initial funding of about $30.8 million is included, with an additional $19.2 million possible through warrants. The funding round features participation from several institutional investors

Company Information

Company

Quoin Pharmaceuticals Ltd

Location

Azrieli Center, Round Tower

Israel

Don't miss Quoin Pharmaceuticals Ltd's next move

Get an email the moment Quoin Pharmaceuticals Ltd raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Quoin Pharmaceuticals Ltd's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Quoin Pharmaceuticals Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.